APA (7th ed.) Citation

Nguyen, J., Nindra, U., Tang, J., Zwieky, W., Hong, J. H., Hong, M., . . . Chua, W. (2026). Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical Trials. Cancers, 18(8), 1242. https://doi.org/10.3390/cancers18081242

Chicago Style (17th ed.) Citation

Nguyen, Jessie, et al. "Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical Trials." Cancers 18, no. 8 (2026): 1242. https://doi.org/10.3390/cancers18081242.

MLA (9th ed.) Citation

Nguyen, Jessie, et al. "Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical Trials." Cancers, vol. 18, no. 8, 2026, p. 1242, https://doi.org/10.3390/cancers18081242.